Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
6,102 people get AMGN articles and Market Currents by email alert.
Get email alerts on AMGN »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Amgen Is A Value And Dividend Growth StoryAbba's Aces • Thu, Jun 13 -
-
Generic Threats To Amgen's BiologicsEmerging Equities • Thu, Jun 6 -
Amgen: Financial Analysis And ValuationShankar N • Fri, May 24 -
-
-
-
-
-
-
-
-
-
-
-
Why Amgen Still Has Valuation Upside RemainingValuentum • Fri, Feb 15 -
-
Is Amgen Running Out Of Steam In 2013?StockRiters • Tue, Jan 22
-
Amgen Management Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 23, 2012
-
Amgen Management Discusses Q2 2012 Results - Earnings Call TranscriptThu, Jul 26, 2012
-
Amgen's CEO Discusses Q1 2012 Results - Earnings Call TranscriptTue, Apr 24, 2012
-
Amgen's CEO Discusses Q4 2011 Results - Earnings Call TranscriptThu, Jan 26, 2012
-
Amgen's CEO Discusses Q3 2011 Results - Earnings Call TranscriptMon, Oct 24, 2011
-
Amgen's CEO Discusses Q2 2011 Results - Earnings Call TranscriptFri, Jul 29, 2011
-
Amgen's CEO Discusses Q1 2011 Results - Earnings Call TranscriptWed, Apr 20, 2011
-
Amgen's CEO Discusses Q4 2010 Results - Earnings Call TranscriptTue, Jan 25, 2011
-
Amgen Management Discusses Q3 2010 Results - Earnings Call TranscriptTue, Oct 26, 2010
-
Amgen Q2 2010 Earnings Call TranscriptFri, Jul 30, 2010
-
Amgen Inc. Q1 2010 Earnings Call TranscriptThu, Apr 22, 2010
-
Amgen, Inc. Q4 2009 Earnings Call TranscriptMon, Jan 25, 2010
-
Amgen, Inc. Q3 2009 Earnings Call TranscriptWed, Oct 21, 2009
-
PR Newswire (Thu, 3:11PM)
-
at MarketWatch.com (Thu, 6:15AM)
-
PR Newswire (Jun 12, 2013)
-
PR Newswire (Jun 12, 2013)
-
PR Newswire (Jun 6, 2013)
-
at CNBC.com (Jun 5, 2013)
-
at CNBC.com (Jun 3, 2013)
-
at CNBC.com (Jun 3, 2013)
-
at MarketWatch.com (Jun 3, 2013)
-
PR Newswire (May 29, 2013)
-
at CNBC.com (May 29, 2013)
-
PR Newswire (May 29, 2013)
-
PR Newswire (May 23, 2013)
-
PR Newswire (May 22, 2013)
-
at CNBC.com (May 20, 2013)
-
PR Newswire (May 16, 2013)
-
PR Newswire (May 15, 2013)
-
PR Newswire (May 9, 2013)
AMGN vs. ETF Alternatives
Company Description
Amgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Company,” “we,” “our” and “us”) is the world’s largest independent biotechnology medicines company. We discover, develop, manufacture and market medicines for grievous illnesses. We focus solely on human therapeutics and... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, March 6, 5:27 PM Amgen, Inc. (AMGN) declares $0.47/share quarterly dividend, in line with previous. Forward yield 2.02%. For shareholders of record May 16. Payable June 07. Ex-div date May 14. (PR) Comment! [Dividends]
- Thursday, December 13, 2012, 5:22 PM Amgen (AMGN) declares $0.47/share quarterly dividend, 31% increase from prior dividend of $0.36. Forward yield 2.11%. For shareholders of record Feb. 13. Payable Mar. 07. Ex-div date Feb. 11. The board approved an increase in share repurchase program of $2.0B. (PR) Comment! [Dividends]
- Thursday, October 11, 2012, 9:11 AM Amgen (AMGN) declares $0.36/share quarterly dividend, in line with previous. Forward yield 1.70%. For shareholders of record Nov 15. Payable Dec 07. Ex-div date Nov 13. (PR) 1 Comment [Dividends]
- Thursday, July 19, 2012, 6:06 PM Amgen (AMGN) declares $0.36/share quarterly dividend, in line with previous. Forward yield 1.8%. For shareholders of record Aug 16. Payable Sep 07. Ex-div date Aug 14. (PR) Comment! [Dividends]
-
- View all 0 replies
-
The Scientist
Nice move today and a vote of confidence from $AMGN. $CYTK current move has a long way to go. - View all 0 replies
-
Philip Davis
Morning Outlook: Cashing Nikkei Longs, QE Reaching It's Limit? $$ $EWJ, $USO, $GLD, $BA $CAT $AMGN $VOD #Futures --http://bit.ly/13Bjtai - View all 1 replies
-
jason2713: Thanks Phil, always enjoy reading your emails you send me.
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 1 replies
-
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
Philip Davis
Morning Outlook: Cashing Nikkei Longs, QE Reaching It's Limit? $$ $EWJ, $USO, $GLD, $BA $CAT $AMGN $VOD #Futures --http://bit.ly/13Bjtai - View all 1 replies
-
jason2713: Thanks Phil, always enjoy reading your emails you send me.
-
- View all 1 replies
-
-
- View all 1 replies
-
-
- View all 2 replies
-
-
-
- View all 4 replies
-
-
fatfat: hey, i sold out of money uncovered puts today. maybe i match it with uncovered calls if apple rallies tomorrow - a naked weeklie straddle..
-
- View all 2 replies
-
-
-
- View all 1 replies
-
Dr. Kris: ...Interesting article on how Amgen is acting like like big pharma: http://seekingalpha.com/a/bbw7
-
The Scientist
CYTK: Wall St completely ignoring great results of ALS and HF drugs. AMGN should just buy them out. Ridiculously undervalued at $70M - View all 2 replies
-
The Scientist: Omecamtiv is a wonder drug that can be used in the ICU like water. It raises CO/SV; lowers BP/HR. Too good to be true.
-
briandiplacido: As a long-time ICU nurse who's seen tons of tachyarrythmia from inotropes, I agree (seems too good to be true). Interesting.
-
- View all 3 replies
-
freefdawatchlist: don't buy more, because if fda delay it by 3 month, the stock may drop. Check out other stock which haven't rallied up till now.
-
-
- View all 3 replies
-
-
